Retail & Innovation: Who Will Decide the Future of Alternative Proteins?
Fr om breakthrough to shelf reality
Over the past decade, alternative proteins—from cultivated meat to precision fermentation and insect-based ingredients—have attracted billions in investment and global attention.
According to Boston Consulting Group, the alternative protein market could reach $290 billion by 2035, potentially accounting for 11% of global protein consumption. Yet despite this optimistic outlook, many products remain stuck between innovation and commercialization.
The bottleneck is increasingly clear: retail.
Getting a product approved in a lab is one thing. Getting it onto shelves—and into shopping baskets—is something else entirely.
Price remains the first barrier
For most consumers, sustainability and innovation still come second to price.
A 2023 global survey by McKinsey & Company found that while more than 50% of consumers express interest in trying alternative proteins, fewer than 20% are willing to pay a premium for them.
This gap is particularly visible in categories like cultivated meat and precision fermentation dairy, wh ere production costs remain significantly higher than conventional alternatives.
Retailers, operating on tight margins, are reluctant to allocate shelf space to products that may struggle with turnover. In retail, curiosity does not equal conversion.
Consumer behaviour: interest without habit
Beyond price, consumer behavior presents a deeper structural challenge.
Alternative proteins often require a shift in привычки, not just a one-time purchase decision. While plant-based products have achieved some level of mainstream acceptance, newer categories—such as insect protein or cultivated meat—still face psychological and cultural resistance.
Data from European Food Safety Authority and consumer studies across Europe show that acceptance of novel foods is highly dependent on:
- familiarity of format
- perceived naturalness
- trust in regulation and safety
Products that resemble existing привычные категории—such as burgers, milk, or ready meals—perform significantly better than entirely new formats.
Retail as gatekeeper—and accelerator
Retailers are no longer passive distributors. They are increasingly acting as curators of innovation.
Major chains in Europe and Asia are testing alternative protein products through:
- limited shelf trials
- private label development
- in-store positioning experiments
Some retailers are even investing directly in food tech startups or forming partnerships to secure early access to innovation.
This shift reflects a broader reality:
Retail determines not only what is available—but what becomes normal.
Placement, pricing strategy and in-store communication all influence whether a product succeeds or fails.
The startup challenge: scaling beyond pilot
For startups, entering retail is one of the hardest transitions.
While early-stage companies often focus on technology and product development, retail demands something different:
- consistent supply
- stable pricing
- clear positioning
- strong branding
Many startups underestimate the complexity of this step.
According to Good Food Institute, global investment in alternative proteins exceeded $14 billion between 2020 and 2022, but only a fraction of companies have successfully scaled into mainstream retail distribution.
The gap between innovation and commercialization remains one of the defining challenges of the sector.
Regulation: enabling or slowing innovation?
Regulatory frameworks play a critical role in shaping market access.
In the European Union, novel foods—including cultivated meat and certain fermentation-derived products—must go through a strict approval process. While this ensures safety, it can also delay market entry by several years.
At the same time, clear regulation is essential for building consumer trust.
Authorities such as the European Commission and EFSA are working to balance innovation with safety, but industry players often call for:
- faster approval timelines
- clearer guidelines
- harmonized standards across markets
Without these, scaling remains difficult.
Beyond hype: building a credible market
The alternative protein sector is now entering a new phase.
The early wave was driven by technology and investment. The next phase will be defined by market performance.
To succeed, companies will need to move beyond innovation alone and address:
- affordability
- taste and quality
- transparency
- clear value propositions
Retailers, in turn, must decide how actively they want to support this transition—whether as passive sellers or active partners in reshaping the food system.
A shared responsibility
The future of alternative proteins will not be decided by a single player.
It will emerge from the interaction between:
- producers developing scalable technologies
- retailers shaping access and visibility
- regulators ensuring safety and trust
- consumers ultimately making purchasing decisions
Each of these actors plays a role in determining whether alternative proteins remain a niche category—or become a meaningful part of the global food system.
Without retail adoption, innovation remains invisible. With it, entirely new categories can become mainstream. The next phase of the food revolution will not be decided in laboratories. It will be decided on supermarket shelves.
